Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completed

DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

NCT00899652
completed

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

NCT00006342
completed

SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer

NCT00900042

Clinical Trials (3)

Showing 3 of 3 trials
NCT00899652

DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Completed
NCT00006342

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

Completed
NCT00900042

SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer

Completed

All 3 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
3